MXPA02003516A - Polymorphic n [3 [[2 (3,4 dimethoxyphenyl) ethyl] amino] propyl] 4 nitro benzamide hydrochloride. - Google Patents

Polymorphic n [3 [[2 (3,4 dimethoxyphenyl) ethyl] amino] propyl] 4 nitro benzamide hydrochloride.

Info

Publication number
MXPA02003516A
MXPA02003516A MXPA02003516A MXPA02003516A MXPA02003516A MX PA02003516 A MXPA02003516 A MX PA02003516A MX PA02003516 A MXPA02003516 A MX PA02003516A MX PA02003516 A MXPA02003516 A MX PA02003516A MX PA02003516 A MXPA02003516 A MX PA02003516A
Authority
MX
Mexico
Prior art keywords
propyl
ethyl
amino
polymorphic
dimethoxyphenyl
Prior art date
Application number
MXPA02003516A
Other languages
Spanish (es)
Inventor
Busby David
Original Assignee
Glaxosmithkline Lab Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Lab Sas filed Critical Glaxosmithkline Lab Sas
Publication of MXPA02003516A publication Critical patent/MXPA02003516A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A polymorphic form of N [3 [[2 (3, 4 dimeth0xyphenyl)ethyl]amino]propyl] 4 nitro benzamide hydrochloride, a process for preparing such a compound and the use of such a compound in medicine.
MXPA02003516A 1999-10-08 2000-10-06 Polymorphic n [3 [[2 (3,4 dimethoxyphenyl) ethyl] amino] propyl] 4 nitro benzamide hydrochloride. MXPA02003516A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923933.7A GB9923933D0 (en) 1999-10-08 1999-10-08 Novel pharmaceutical
PCT/GB2000/003847 WO2001027071A1 (en) 1999-10-08 2000-10-06 Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride

Publications (1)

Publication Number Publication Date
MXPA02003516A true MXPA02003516A (en) 2004-09-10

Family

ID=10862442

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02003516A MXPA02003516A (en) 1999-10-08 2000-10-06 Polymorphic n [3 [[2 (3,4 dimethoxyphenyl) ethyl] amino] propyl] 4 nitro benzamide hydrochloride.

Country Status (18)

Country Link
EP (1) EP1218334A1 (en)
JP (1) JP2003511437A (en)
KR (1) KR20020043618A (en)
CN (1) CN1384817A (en)
AU (1) AU7546000A (en)
BR (1) BR0014591A (en)
CA (1) CA2386845A1 (en)
CZ (1) CZ20021189A3 (en)
GB (1) GB9923933D0 (en)
HK (1) HK1049147A1 (en)
HU (1) HUP0203582A2 (en)
IL (1) IL148966A0 (en)
MX (1) MXPA02003516A (en)
NO (1) NO20021639L (en)
PL (1) PL354137A1 (en)
TR (1) TR200200949T2 (en)
WO (1) WO2001027071A1 (en)
ZA (1) ZA200202679B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471144C (en) * 2002-01-09 2011-06-07 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
PT2091910E (en) * 2006-12-06 2014-11-18 Conatus Pharmaceuticals Inc Crystalline forms of (3 s) -3- [n- (n' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluoro phenoxy) -4-oxopenta noic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726267B1 (en) * 1994-10-26 1998-01-02 Smithkline Beecham Lab NOVEL ARRHYTHMIC AGENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR PREPARING THEM
GB9706376D0 (en) * 1997-03-27 1997-05-14 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
HUP0203582A2 (en) 2004-03-01
JP2003511437A (en) 2003-03-25
TR200200949T2 (en) 2002-08-21
BR0014591A (en) 2002-06-11
IL148966A0 (en) 2002-11-10
PL354137A1 (en) 2003-12-29
NO20021639D0 (en) 2002-04-05
NO20021639L (en) 2002-05-30
HK1049147A1 (en) 2003-05-02
GB9923933D0 (en) 1999-12-08
WO2001027071A1 (en) 2001-04-19
ZA200202679B (en) 2003-05-28
CN1384817A (en) 2002-12-11
CZ20021189A3 (en) 2002-09-11
CA2386845A1 (en) 2001-04-19
KR20020043618A (en) 2002-06-10
EP1218334A1 (en) 2002-07-03
AU7546000A (en) 2001-04-23

Similar Documents

Publication Publication Date Title
HK1043365B (en) N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
BG106747A (en) Novel composition and use
SE9704545D0 (en) Novel compounds
HUP0004400A3 (en) Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
IL136369A0 (en) Adamantane derivatives
PL350412A1 (en) 2−amino−benzoxazinone derivatives for the treatment of obesity
MX9605128A (en) Neurokinine (tachykinine) antagonists.
HUP9802808A3 (en) N-(4-carbamido-phenyl)-phenylglycin-amid derivatives, process for preparing them, pharmaceuticals containing them and intermediates
IL130102A (en) Aminoguanidines and alkoxyguanidines as protease inhibitors, pharmaceutical compositions containing the same and processes for preparing the same
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
GR3036305T3 (en) Chiral methyl phenyl oxazolidinones
GB2234510B (en) Ethyl 6-bromo-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindole-3-carboxylate hydrochloride monohydrate, process for & compositions thereof
IL140767A0 (en) Polycyclic thiazolidin-2- ylidene amines, process for their preparation, and their use as pharmaceuticals
MXPA02003516A (en) Polymorphic n [3 [[2 (3,4 dimethoxyphenyl) ethyl] amino] propyl] 4 nitro benzamide hydrochloride.
HUP9601977A2 (en) Mixtures containing amino acides and amides, process for producing the amides, and pharmaceutical compositions containing these mixtures and/or amides
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
ZA924236B (en) A process for the preparation of n-(2,6-dichlorophenyl)-n-phenyl-n-(chloroacetyl)-amine
ZA983523B (en) New benzyl amine derivatives and phenyl ethyl amine derivatives process for preparing them and their use as medicaments
BG105999A (en) Treatment of osteoarthritis
GB2239241B (en) Novel process for the preparation of n-(2-amino-3,5-dibromobenzyl)-trans-4-amino-cyclohexanol
FI945414A0 (en) Process for the preparation of N, N-disubstituted aminophenol
GB2242911B (en) Process for preparing aromatic amine compounds and reducing agent therefor
IL136825A0 (en) Process for the preparation of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine
EP0619298A3 (en) (Phenylmethylene)-2-(alkyl)-1- omega-(amino)-alkoxyimino -cycloalkane derivatives, a process for preparing them as well as medicaments containing them and the use of them.